Zofran

From Protocopedia
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Section 8 - MEDICATION GUIDELINES

ANTIEMETICS

Ondansetron Hydrochloride (ZOFRAN) / Antiemetic

DESCRIPTION:

  • This medication is used to prevent or decrease the severity of nausea and vomiting.

ACTION:

  • Blocks the effects of the hormone serotonin at the 5-HT3 -receptor sites (located in the vagal nerve terminals) that cause vomiting.
  • Half-life 3.5 - 5.5 hr

INDICATIONS:

  • Severe, persistent vomiting.

CONTRAINDICATIONS:

  • Known hypersensitivity.

PRECAUTIONS:

  • Patients with liver impairment
  • Pregnancy-Category B- Studies have revealed no evidence of impaired fertility or harm to the fetus.
  • May cause an extrapyramidal reaction.
  • Little information is available about dosage in pediatric patients under 2 years of age.

DOSAGE:

  • Currently supplied in 4mg/2ml vials and 4 mg oral disintegrating tablets (ODT)
  • Adult: 4mg slow IVP or 1 ODT tab.
    • When administering IV, consider diluting in 10-20 ml normal saline to aid in administering slowly or 4mg/2ml deep IM in a large muscle.
  • Pediatrics:
    • Premie - 8 years old - ADMINISTER 0.15 mg/kg slow IVP (mag of 4 mg)
    • 9 years and older - 4 mg slow IVP
    • For PO administration:
      • 1-3 year old – ADMINISTER ½ ODT tab
      • 4 years and older: ADMINISTER 1 ODT tab
  • NOTE: Use PO administration route for conscious patients ONLY.